Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2025-12-24 @ 1:36 PM
NCT ID:
NCT02453295
Eligibility Criteria:
Inclusion:
* men and women who are 18 years of age or older;
* who have been diagnosed with UL or LL SLC a minimum of 3 months prior to data collection;
* who are in the management phase of SLC treatment at the time of enrolment;
* are English speaking;
* are able to consent.
Exclusion:
* being in the active phase of LE treatment. Because this type of acute care involves intensive and time-consuming treatment, which would make participation in the proposed research extremely challenging, we will enroll only men and women who are in the management phase of treatment.
* non-English speaking. Non-English speaking participants will be excluded given time and resource constraints. In our recent qualitative study of SLC, no non-English speaking potential participants from Ottawa expressed an interest in the study. Future research (to expand the pilot intervention, if successful) will be bilingual.
* As noted previously individuals scoring in the top \~30% (n=16) in terms of hope according to the MIQ, will be excluded from the study.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02453295
Study Brief:
Protocol Section:
NCT02453295